Recital 7, Decision_act (EU) 2019/1951

In force

Except for the expiry date of the approval, tebuconazole remains approved for use in biocidal products of product-type 8 subject to the specifications and conditions set out in Annex I to Directive 98/8/EC,

  • celex=31998L0008